Gastritis. Chronic gastritis, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Using three drugs regimen (bismuth sub citrate (120mg/kg QD), tetracycline (500mg QD) and metronidazole (400 mg/kg TD)) + Q10 coenzyme (2 mg/kg/day) for 6 weeks.
Th
Treatment - Drugs
Intervention group: Using three drugs regimen (bismuth sub citrate (120mg/kg QD), tetracycline (500mg QD) and metronidazole (400 mg/kg TD)) + Q10 coenzyme (2 mg/kg/day) for 6 weeks.
The types and dos
Control group: Using three drugs regimen (bismuth sub citrate (120mg/kg QD), tetracycline (500mg QD) and metronidazole (400 mg/kg TD)) + placebo (lactolose) for 6 weeks.
The types and dosages of drug
Sponsors
Vice Chancellor for researchesand Technology, Ilam University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Including criteria: h. pylori infected gastric patients Excluding criteria: pregnancy; lactation; recent antibiotic application (6 recent weeks); recent attempt for h. pylori treatment; recent surgery of stomach; positive history of alcohol consumption or addiction; having infections or malignancies in other organs; cardiovascular diseases; diabetes; IBD .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total antioxidant capacity (TAC). Timepoint: Start and end of study. Method of measurement: Serum level of studied marker by standard kits.;Glutation peroxidise. Timepoint: Start and end of study. Method of measurement: Serum level of studied marker by standard kits.;Malondialdehyde. Timepoint: Start and end of study. Method of measurement: Serum level of studied marker by standard kits. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Asadollahi Ruhangiz
Ilam University of Medical Sciences
Outcome results
None listed